Probiotics in dermatologic practice

Nutrition

Volumn 32, Issue 3, 2016, Pages 289-295

  Fuchs Tarlovsky, Vanessa ^a   Marquez Barba, María Fernanda ^a   Sriram, Krishnan ^b,c  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b Jr Hospital of Cook County   (United States)

^c ADVOCATE HEALTH CARE   (United States)

Author keywords

Acne; Atopic dermatitis; Dermatology; Prebiotics; Probiotics; Synbiotics

Indexed keywords

ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; GLUCOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MALTODEXTRIN; PREBIOTIC AGENT; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGIC FACTOR;

ACNE; ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; META ANALYSIS; META ANALYSIS (TOPIC); MICROBIAL COLONIZATION; MILK; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SCORING ATOPIC DERMATITIS SCORE; SCORING SYSTEM; SKIN CANDIDIASIS; SYSTEMATIC REVIEW; TH1 CELL; TH2 CELL; DERMATITIS, ATOPIC; DERMATOLOGY; MICROBIOLOGY; SKIN;

DERMATITIS, ATOPIC; DERMATOLOGY; HUMANS; IMMUNOLOGIC FACTORS; PREBIOTICS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN;

EID: 84961206630     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.09.001     Document Type: Review

References (70)

1. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014, 11:506-514.
2. Bowe W., Patel N.B., Logan A.C. Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine. Benef Microbes 2014, 5:185-199.
3. Kumar S., Mahajan B.B., Kamra N. Future perspective of probiotics in dermatology: an old wine in new bottle. Dermatol Online J 2014, 20:13030-13033.
4. Gourbeyre P., Denery S., Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 2011, 89:685-695.
5. Holzapfel W.H., Schillinger U. Introduction to pre- and probiotics. Food Res Int 2002, 35:109-116.
6. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., et al. Demonstration of safety of probiotics-a review. Int J Food Microbiol 1998, 44:93-106.
7. Naruszewicz M., Johansson M.L., Zapolska-Downar D., Bukowska H. Effect of Lactobacillus plantarum 299 v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002, 76:1249-1255.
8. Imaizumi K., Nakatsu Y., Sato M., Sedarnawatia Y., Suganoa M. Effects of xylooligosaccharides on blood glucose, serum and liver lipids and cecum short-chainfFatty acids in diabetic rats. Agric Biol Chem 2014, 55:199-205.
9. Caramia G. Probiotics: from Metchnikoff to the current preventive and therapeutic possibilities. Pediatr Med Chir 2004, 26:19-33.
10. Fujimura K.E., Slusher N.A., Cabana M.D., Lynch S.V. Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther 2010, 8:435-454.
11. Baquerizo Nole K.L., Yim E., Keri J.E. Probiotics and prebiotics in dermatology. J Am Acad Dermatol 2014, 71:814-821.
12. Leung D.M., Eichenfield L.F., Boguniewicz M. Atopic dermatitis. Fitzpatrick's Dermatology in General Medicine 2012, 1533-1576. McGraw-Hill, New York, NY. 8th ed. L. Goldsmith, S. Katz, B. Gilchrest, A.S. Paller, D. Leffell, K. Wolff (Eds.).
13. Finch J., Munhutu M.N., Whitaker-Worth D.L. Atopic dermatitis and nutrition. Clin Dermatol 2010, 28:605-614.
14. Anderson P.C., Dinulos J.G. Atopic dermatitis and alternative management strategies. Curr Opin Pediatr 2009, 21:131-138.
15. Foolad N., Brezinski E.A., Chase E.P., Armstrong A.W. Effect of nutrient supplementation on atopic dermatitis in children. JAMA Dermatol 2013, 149:350-355.
16. Foolad N., Armstrong A.W. Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children. Benef Microbes 2014, 5:151-160.
17. Panduru M., Panduru N.M., Salavastru C.M., Tiplica G.S. Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol 2015, 29:232-242.
18. Tang M.L. Probiotics and prebiotics: immunological and clinical effects in allergic disease. Nestle Nutr Workshop Ser Pediatr Program 2009, 64:219-251.
19. van der A., Heymans H.S., van Aalderen W.M., Sprikkelman A.B. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. PediatrAllergy Immunol 2010, 21:355-367.
20. Lee J., Seto D., Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008, 121:116-121.
21. Kunz B., Oranje A.P., Labreze L., Stalder J.F., Ring J., Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997, 195:10-19.
22. Flohr C., Pascoe D., Williams H.C. Atopic dermatitis and the "hygiene hypothesis": Too clean to be true?. Br J Dermatol 2005, 152:202-216.
23. Yesilova Y., Calka O., Akdeniz N., Berktaş M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 2012, 24:189-193.
24. Passeron T., Lacour J.P., Fontas E., Ortonne J.P. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006, 61:431-437.
25. Finlay A.Y., Khan G.K. Dermatology Life Quality Index-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19:210-216.
26. Drago L., Iemoli E., Rodighiero V., Nicola L., De Vecchi E., Piconi S. Effects of Lactobacillus salivarius LS01 treatment on adult atopic dermatitis: a randomized placebo-controlled study. Int J Immunopathol Pharmacol 2011, 24:1037-1048.
27. Iemoli E., Trabattoni D., Parisotto S., Borgonovo L., Toscano M., Rizzardini G., et al. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol 2012, 46:33-40.
28. Misery L. Therapeutic perspectives in atopic dermatitis. Clin Rev Allergy Immunol 2011, 41:267-271.
29. Drago L., Toscano M., De Vecchi E., Piconi S., Iemoli E. Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol 2012, 46:56-63.
30. Kalliomaki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361:1869-1871.
31. Kukkonen K., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007, 119:192-198.
32. Kuitunen M., Kukkonen K., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009, 123:335-341.
33. Viljanen M., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005, 60:494-500.
34. Gerasimov S.V., Vasjuta V.V., Myhovych O.O., Bondarchuk L.I. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 2010, 11:351-361.
35. Flinterman A.E., Knol E.F., van Ieperen-van Dijk A.G., Timmerman H.M., Knulst A.C., Bruijnzeel-Koomen C.A., et al. Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. Int Arch Allergy Immunol 2007, 143:237-244.
36. Lahtinen S., Ouwehand A. Mecanisms of Probiotics. Handbook of probiotics and prebiotics 2009, 377-421. John Wiley & Sons, Hoboken, NJ. 2nd ed. Y.C. Lee, S. Salminen (Eds.).
37. Schultz M., Timmer A., Herfarth H.H., Sartor R.B., Vanderhoof J.A., Rath H.C. Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol 2004, 15:4-5.
38. Isolauri E., Joensuu J., Suomalainen H., et al. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995, 13:310-312.
39. Kalliomaki M.A., Walker W.A. Physiologic and pathologic interactions of bacteria with gastrointestinal epithelium. Gastroenterol Clin North Am 2005, 34:383-399.
40. Lammers K.M., Helwig U., Swennen E., Rizzello F., Venturi A., Caramelli E., et al. Effect of probiotic strains on interleukin 8 production by HT29/19 A cells. Am J Gastroenterol 2002, 97:1182-1186.
41. Ruiz P., Hoffmann M., Szcesny S., Blaut M., Haller D. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology 2005, 115:441-450.
42. Neish A.S. Bacterial inhibition of eukaryotic pro-inflammatory pathways. Immunol Res 2004, 29:175-186.
43. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., et al. Prokaryotic regulation of epithelial responses by inhibition of NF kappa B-alpha ubiquitination. Science 2000, 289:1560-1563.
44. Hart A.L., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53:1602-1609.
45. He F., Morita H., Hashimoto H., Hosoda M., Kurisaki J., Ouwehand A.C., et al. Intestinal Bifidobacterium species induce varying cytokine production. J Allergy Clin Immunol 2002, 109:1035-1036.
46. Pohjavuori E., Viljanen M., Korpela R., Kuitunen M., Tiittanen M., Vaarala O., et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol 2004, 114:131-136.
47. Maassen C.B., van Holten J.C., Balk F., Heijne den Bak-Glashouwer M.J., Leer R., Laman J.D., et al. Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response. Vet Q 1998, 20:81-83.
48. Fang H., Elina T., Heikki A., Seppo S. Modulation of humoral immune response through probiotic intake. FEMS Immunol Med Microbiol 2000, 29:47-52.
49. Mullie C., Yazourh A., Thibault H., Odou M.F., Singer E., Kalach N., et al. Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatr Res 2004, 56:791-795.
50. Kukkonen K., Nieminen T., Poussa T., Savilahti E., Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy-a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol 2006, 17:416-421.
51. Pessi T., Sutas Y., Hurme M., Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000, 30:1804-1808.
52. Sheil B., McCarthy J., O'Mahony L. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 2004, 53:694-700.
53. von der Weid T., Bulliard C., Schiffrin E.J. Induction by a lactic acid bacterium of a population of CD4 T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol 2001, 8:695-701.
54. Kirjavainen P.V., Salminen S.J., Isolauri E. Probiotic bacteria in the management of atopic disease: Underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003, 36:223-227.
55. Goldin B.R., Gorbach S.L., Saxelin M., Barakat S., Gualtieri L., Salminen S. Survival of Lactobacillus species in human gastrointestinal tract. Dig Dis Sci 1992, 37:121-128.
56. Kaila M., Isolauri E., Sepp E., Mikelsaar M., Salminen S. Colonisation of infants with Lactobacillus GG during acute rotavirus diarrhea. Biosci Microflora 1998, 17:149-151.
57. Alander M., Satokari R., Korpela R., Saxelin M., Vilpponen-Salmela T., Mattila-Sandholm T., et al. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999, 65:351-354.
58. Benno Y., He F., Hosoda M. Effects of Lactobacillus GG yoghurt on human intestinal microecology in Japanese subjects. Nutr Today 1996, 31:9-11.
59. Majamaa H., Isolauri E., Saxelin M., Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995, 20:333-338.
60. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002, 168:171-178.
61. Matsumoto M., Ebata T., Hirooka J., Hosoya R., Inoue N., Itami S., et al. Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis. Ann Allergy Asthma Immunol 2014, 113:209-216.
62. Niers L.E., Timmerman H.M., Rijkers G.T., van Bleek G.M., van Uden N.O., Knol E.F., et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 2005, 35:1481-1489.
63. Rasche C., Wolfram C., Wahls M., Worm M. Differential immunomodulating effects of inactivated probiotic bacteria on the allergic immune response. Acta Derm Venereol 2007, 87:305-311.
64. Stokes J.H. The effect on the skin of emotional and nervous states: theoretical and practical consideration of a gastrointestinal mechanism. Arch Dermatol Syphilol 1930, 22:962-993.
65. Bowe W.P., Logan A.C. Acne vulgaris, probiotics and the gut-brain-skin axis-back to the future?. Gut Pathog 2011, 3:4749-4753.
66. Wang Y., Kuo S., Shu M., Yu J., Huang S., Dai A., et al. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol 2014, 98:411-424.
67. Jung G.W., Tse J.E., Guiha I., Rao J. Prospective, randomized,open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J Cutan Med Surg 2013, 17:114-122.
68. Williams H.C., Grindlay D.J. What's new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 2. Disease prevention and treatment. Clin Exp Dermatol 2010, 35:223-227.
69. Allen S.J., Jordan S., Storey M., Thornton C.A., Gravenor M.B., Garaiova I., et al. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child 2014, 99:1014-1019.
70. Mailänder-Sánchez D., Wagener J., Schaller M. Potential role of probiotic bacteria in the treatment and prevention of localised candidiasis. Mycoses 2012, 55:17-26.